Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Analyst Ratings

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 3 Sell Rating(s), 4 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $194.23 (16.38% upside)

Analysts' Ratings History for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetActions
7/25/2016WedbushReiterated RatingOutperform$239.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2016Cantor FitzgeraldInitiated CoverageSell$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Robert W. BairdReiterated RatingOutperform$332.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Needham & Company LLCReiterated RatingBuy$350.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016FBR & CoReiterated RatingHold$192.00 -> $200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Leerink SwannReiterated RatingHold$144.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016BMO Capital MarketsReiterated RatingBuy$221.00 -> $219.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Barclays PLCReiterated RatingBuy$200.00 -> $205.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Credit Suisse Group AGReiterated RatingBuy$200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Morgan StanleyReiterated RatingUnderweight$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016JMP SecuritiesReiterated RatingMarket Outperform$200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Cowen and CompanyBoost Price TargetOutperform$212.00 -> $215.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$114.00 -> $128.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/9/2016Bank of America Corp.Reiterated RatingSell$144.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016S&P Equity ResearchReiterated RatingAverage$100.60 -> $111.91View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Royal Bank Of CanadaReiterated RatingOutperform$490.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015MLV & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Deutsche Bank AGBoost Price TargetBuy$300.00 -> $400.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015NomuraSet Price TargetBuy$440.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Summer StreetReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Intercept Pharmaceuticals (NASDAQ:ICPT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/5/2016Q1($3.60)($5.17)$0.64 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415($3.15)($3.62)$0.43 million$0.45 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($2.74)($2.10)$0.42 million$0.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($1.95)($1.99)$2.17 million$0.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($1.75)($1.78)$1.70 million$1.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414($1.53)($1.63)$0.42 million$0.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q3($1.02)($1.69)$0.46 million$0.45 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.12)($0.79)$400.00 million$405.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014($0.72)($1.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2014Q4 13($0.70)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/14/2013Q313($0.51)($1.65)$0.89 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2013Q2 2013($0.51)($0.79)$0.40 million$0.41 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intercept Pharmaceuticals (NASDAQ:ICPT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($4.29)($3.65)($3.83)
Q2 20165($4.12)($3.00)($3.65)
Q3 20164($4.72)($3.17)($3.92)
Q4 20164($4.50)($2.87)($3.87)
Q1 20171($4.19)($4.19)($4.19)
Q2 20171($4.04)($4.04)($4.04)
Q3 20171($3.82)($3.82)($3.82)
Q4 20171($3.52)($3.52)($3.52)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intercept Pharmaceuticals (NASDAQ:ICPT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intercept Pharmaceuticals (NASDAQ:ICPT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/5/2016Barbara Gayle DuncanCAOSell146$145.11$21,186.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2016David ShapiroCMOSell163$145.11$23,652.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2016Lisa BrightInsiderSell155$145.11$22,492.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2016Mark PruzanskiCEOSell714$145.11$103,608.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Lisa BrightInsiderSell251$137.50$34,512.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Rachel McminnInsiderSell130$147.49$19,173.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Barbara Gayle DuncanCFOSell144$130.76$18,829.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016David ShapiroCMOSell165$130.76$21,575.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Lisa BrightInsiderSell153$130.76$20,006.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Mark PruzanskiCEOSell708$130.76$92,578.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Lisa BrightInsiderSell241$115.22$27,768.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Rachel McminnInsiderSell128$103.56$13,255.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2016Lisa BrightinsiderSell728$125.52$91,378.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Barbara Gayle DuncanCFOSell468$145.90$68,281.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016David ShapiroCMOSell533$145.90$77,764.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Mark PruzanskiCEOSell2,126$145.90$310,183.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Rachel McminnInsiderSell469$145.90$68,427.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015Lisa BrightInsiderSell1,150$182.96$210,404.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015David ShapiroCMOSell4,264$178.53$761,251.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015David ShapiroCMOSell3,500$204.15$714,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Klaus R. Dr VeitingerDirectorSell1,000$198.25$198,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Rachel McminnInsiderSell125$160.24$20,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2015Barbara Gayle DuncanCFOSell1,054$163.17$171,981.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2015David ShapiroCMOSell1,140$160.12$182,536.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015Nicole WilliamsDirectorSell973$194.82$189,559.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015David ShapiroCMOSell3,500$191.28$669,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015David ShapiroCMOSell4,272$209.37$894,428.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Nicole WilliamsDirectorSell973$279.01$271,476.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2015Mark PruzanskiCEOSell12,500$250.00$3,125,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Luciano AdoriniInsiderSell4,067$579.93$2,358,575.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Barbara Gayle DuncanCFOSell1,000$242.10$242,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015David ShapiroCMOSell3,781$238.66$902,373.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Nicole WilliamsDirectorSell974$265.14$258,246.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015David ShapiroCMOSell3,500$241.58$845,530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Luciano AdoriniInsiderSell4,000$248.40$993,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Klaus R Dr VeitingerDirectorSell391$279.07$109,116.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015Luciano AdoriniInsiderSell4,000$259.97$1,039,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Nicole WilliamsDirectorSell974$278.50$271,259.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Luciano AdoriniInsiderSell4,000$269.64$1,078,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015David ShapiroCMOSell3,459$275.25$952,089.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2015Orbimed Advisors LlcDirectorSell157,200$286.75$45,077,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Orbimed Advisors LlcDirectorSell207,800$274.41$57,022,398.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015Jonathan SilversteinDirectorSell45,600$272.00$12,403,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Jonathan SilversteinDirectorSell159,400$275.18$43,863,692.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015David ShapiroCMOSell3,500$286.90$1,004,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Klaus R Dr VeitingerDirectorSell233$150.01$34,952.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Barbara Gayle DuncanCFOSell141$176.49$24,885.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Daniel Paul ReganInsiderSell146$176.49$25,767.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015David ShapiroCMOSell664$172.63$114,626.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Mark PruzanskiCEOSell461$176.49$81,361.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Barbara Gayle DuncanCFOSell1,000$156.40$156,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014David ShapiroCMOSell4,790$158.82$760,747.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Srinivas AkkarajuDirectorBuy2,000$167.19$334,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Klaus R Dr VeitingerDirectorSell233$175.95$40,996.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Mark PruzanskiCEOSell10,000$259.41$2,594,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2014Klaus R Dr VeitingerDirectorSell391$223.65$87,447.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2014David ShapiroCMOSell5,020$231.63$1,162,782.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Barbara Gayle DuncanCFOSell1,000$233.12$233,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014David ShapiroCMOSell4,188$231.17$968,139.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Mark PruzanskiCEOSell10,000$228.82$2,288,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014David ShapiroCMOSell4,000$281.19$1,124,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Klaus R Dr VeitingerDirectorSell391$280.50$109,675.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Mark PruzanskiCEOSell10,000$286.49$2,864,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014David ShapiroCMOSell10,000$293.93$2,939,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Orbimed Advisors LlcDirectorSell111,258$298.06$33,161,559.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Jonathan SilversteinDirectorSell50,000$295.59$14,779,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014David ShapiroCMOSell4,774$291.49$1,391,573.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Daniel Paul ReganInsiderSell8,124$325.70$2,645,986.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Klaus R Dr VeitingerDirectorSell316$345.62$109,215.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Mark PruzanskiCEOSell10,000$226.72$2,267,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Klaus R Dr VeitingerDirectorSell391$219.15$85,687.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Lorenzo TallarigoDirectorSell2,000$243.06$486,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2014David ShapiroCMOSell5,036$244.73$1,232,460.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Mark PruzanskiCEOSell10,000$250.61$2,506,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014David ShapiroCMOSell4,000$278.15$1,112,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Mark PruzanskiCEOSell10,000$230.60$2,306,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Lorenzo TallarigoDirectorSell2,007$254.68$511,142.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Mark PruzanskiCEOSell10,000$263.17$2,631,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2014Mark PruzanskiCEOSell10,000$242.22$2,422,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Barbara Gayle DuncanCFOSell1,154$279.00$321,966.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2014Lorenzo TallarigoDirectorSell349,318$317.71$110,981,821.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Orbimed Advisors LlcDirectorSell81,305$320.00$26,017,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2014Luciano AdoriniInsiderSell2,000$283.90$567,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2014David ShapiroCMOSell5,393$331.83$1,789,559.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014David ShapiroCMOSell4,456$437.49$1,949,455.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2014Paolo FundaroDirectorSell7,246$375.26$2,719,133.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Mark PruzanskiCEOSell10,000$273.68$2,736,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Srinivas AkkarajuDirectorSell3,250$267.94$870,805.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2014David ShapiroCMOSell4,928$71.85$354,076.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Lorenzo TallarigoDirectorSell1,839$67.41$123,966.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Luciano AdoriniInsiderSell1,634$67.41$110,147.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2013David ShapiroCMOSell5,016$62.11$311,543.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Francesco MicheliMajor ShareholderSell124,912$62.50$7,807,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Jonathan SilversteinDirectorSell40,088$62.50$2,505,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Luciano AdoriniInsiderSell2,000$55.51$111,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Francesco MicheliMajor ShareholderSell1,123,415$62.50$70,213,437.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Orbimed Advisors LlcDirectorSell376,585$62.50$23,536,562.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2013David ShapiroCMOSell4,392$72.80$319,737.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Luciano AdoriniInsiderSell2,000$61.07$122,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2013Mark PruzanskiCEOSell25,000$52.00$1,300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Mark PruzanskiCEOSell12,500$49.02$612,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Luciano AdoriniInsiderSell2,000$44.18$88,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013David ShapiroCMOSell5,016$49.20$246,787.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013David ShapiroCMOSell4,754$45.04$214,120.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Mark PruzanskiCEOSell12,500$45.98$574,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Paolo FundaroDirectorSell4,759$46.13$219,532.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2013Luciano AdoriniInsiderSell2,000$49.44$98,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Mark PruzanskiCEOSell25,000$50.05$1,251,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013Mark PruzanskiCEOSell37,500$46.36$1,738,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2013Barbara Gayle DuncanCFOSell25,000$45.39$1,134,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2013David ShapiroCMOSell4,369$43.63$190,619.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2013Mark PruzanskiCEOSell12,500$40.06$500,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2013Luciano AdoriniInsiderSell2,000$37.07$74,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2013Mark PruzanskiCEOSell25,000$38.25$956,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Barbara Gayle DuncanCFOSell50,575$34.50$1,744,837.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2013David ShapiroCMOSell5,016$32.72$164,123.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Barbara Gayle DuncanCFOSell6,225$34.50$214,762.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Barbara Gayle DuncanCFOSell28,200$34.50$972,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013David ShapiroCMOSell5,016$31.31$157,050.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2013David ShapiroCMOSell3,750$34.41$129,037.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2012Jonathan SilversteinDirectorBuy333,334$15.00$5,000,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intercept Pharmaceuticals (NASDAQ:ICPT)
DateHeadline
07/28/16 07:34 AMCarmignac Gestion Bought A Lot More Intercept Pharmaceuticals ... - Finance Daily
07/28/16 06:18 AMIntercept to Report Second Quarter 2016 Financial Results on August 4 and Present at Upcoming Conference - [at noodls] - NEW YORK, July 28, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, ...
07/27/16 07:24 AMCan Shares Of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Hit $332? - Investor Newswire
07/26/16 07:30 AMMerck (MRK) Q2 Earnings: Will The Stock Pull A Surprise?
07/25/16 09:09 AMVertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?
07/22/16 04:31 PMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 04:31 PMTrading Examination: Performance check on Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/22/16 04:31 PMInvestor Attention Turning to Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Engelwood Daily
07/22/16 04:31 PMBroker Outlook For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Fiscal Standard
07/22/16 04:31 PMAttention Grasping Stock With Upward Momentum: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/22/16 04:02 PMINTERCEPT PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters t -
07/22/16 07:32 AMIntercept Pharmaceuticals Incorporated (NASDAQ:ICPT) Shorted Shares Increased By 2.43% - Press Telegraph
07/22/16 07:32 AMHigh Expectations Remain For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/20/16 02:33 PMSession Focus: Performance Watch on Shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/20/16 02:33 PMInvestor Gauge: Price Target and Earnings Review for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/20/16 02:33 PMEPS Growth in Focus for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/20/16 07:34 AMEquity Roundup: Stock Performance Focus on Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/20/16 07:34 AMShares Positive Over the Past Month: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/19/16 04:40 PMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT): Stock Insight and Session Performance Spotcheck - Press Telegraph
07/19/16 04:40 PMAnalysts Bullish on Stock: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/19/16 04:40 PMSession Focus - Highlighting Shares of: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/19/16 04:40 PMConsensus Analyst Target Price Check for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/19/16 04:40 PMIs $332 Price Target Attainable For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)? - Investor Newswire
07/19/16 04:39 PMInvestors are Intently Watching Shares of: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/18/16 04:45 PMSession Activity Monitor: Stock Focus on Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/18/16 04:45 PMTracking Trading Performance for: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/18/16 04:45 PMMarket Motion Watch - Focus on Shares of: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/18/16 09:48 AMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Taking a Look at the Current Company Impact Score - Press Telegraph
07/17/16 04:08 PMCompany Shares in Focus: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/17/16 04:08 PMTrading Focus on Shares of: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - TGP
07/17/16 04:08 PMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Earnings Review and Target Watch - TGP
07/17/16 08:58 AMShare Performance Summary for: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/15/16 03:38 PMAnalysts Forecast 27% Upside For FBT
07/15/16 08:02 AMConsensus Target and Stock Rating Report: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Telanagana Press
07/15/16 08:02 AMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 04:57 PMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Earnings Rundown and Analyst Rating Recap - Telanagana Press
07/13/16 04:57 PMStock Performance Summary on Shares of: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Telanagana Press
07/13/16 04:57 PMHow Analysts Feel About Intercept Pharmaceuticals Inc After Today's Huge Decline? - Press Telegraph
07/13/16 04:57 PMCompany Sentiment Score Update:Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/13/16 07:28 AMStrong Sell Calls For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) At 2 - Investor Newswire
07/13/16 07:28 AMWashington Trust Bank Lowers stake in Intercept Pharmaceuticals Inc (ICPT) - Trade Calls
07/11/16 04:40 PMTrading Review - Company in Focus: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Telanagana Press
07/11/16 04:40 PMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Earnings Recap and Sell-side Recommendation Review - Telanagana Press
07/11/16 04:40 PMImpact Score and Stock Sentiment Outlook :Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/11/16 04:40 PMStock Performance Rundown on: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/11/16 04:21 PMINTERCEPT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers -
07/11/16 07:24 AMIntercept Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ICPT-US : July 11, 2016 -
07/10/16 08:55 AMPrice Target Review and Earnings Check on Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Press Telegraph
07/08/16 04:43 PMSession Update - Stock in Motion: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) - Telanagana Press
07/08/16 04:43 PMIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Wall Street Rating Watch and Earnings Glance - Telanagana Press

Social

About Intercept Pharmaceuticals

Intercept Pharmaceuticals logoIntercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). The Company is developing OCA for the treatment of liver diseases, such as primary biliary cirrhosis (PBC), non-alcoholic steatoheptitis (NASH), primary sclerosing cholangitis (PCS) and biliary atresia. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ICPT
  • CUSIP: 45845P10
Key Metrics:
  • Previous Close: $166.90
  • 50 Day Moving Average: $148.41
  • 200 Day Moving Average: $134.47
  • P/E Ratio: N/A
  • P/E Growth: -1.33
  • Market Cap: $4.10B
  • Beta: -2.45
  • Current Year EPS Consensus Estimate: $-16.94 EPS
  • Next Year EPS Consensus Estimate: $-14.54 EPS
Additional Links:
Intercept Pharmaceuticals (NASDAQ:ICPT) Chart for Thursday, July, 28, 2016